Central Europe
CT Interactive Enters the Slovakian Regulated Market

CT Interactive has entered the Slovakian regulated market after completing the process of obtaining certificates for offering specially selected content and solutions. The testing and certifying have covered all aspects of the game offerings, and CT Interactive has met the extensive requirements.
“We are very pleased to take this step into the Slovakian market and look forward to launching our games with local operators soon,” Lachezar Petrov, CEO at CT Interactive, said.
He added that the company continues to deliver on its strategy to grow by strengthening positions in the regulated markets.
“We pride ourselves on being a reliable, trustworthy and secure partner to customers and players,” he added.
CT Interactive has prepared an initial package of market-tailored games for Slovakia. The original games are 20 Star Party; Big Joker; Cherry Crown; Devil’s Fruits; Hot 7’s X 2; Lucky Clover, Pick the Pig, Hell’s Sevens, Coffee Magic, Chilli Fruits, and more are very soon to come along with its intriguing Jackpot concepts.
“Now that we have entered the Slovak market, we are thrilled to continue delivering high-quality, enthralling games and gaming solutions to our partners,” Lachezar Petrov said.
-
Latest News5 days ago
PG Soft releases fantasy-inspired Jack the Giant Hunter slot
-
Africa5 days ago
Jelly Entertainment Enters into Partnership with betPawa
-
Asia5 days ago
Nazara Publishing Launches Pokerverse VR
-
Latest News5 days ago
Kambi and JOI gaming (JVH gaming & entertainment group) announce multi-year online sportsbook partnership extension
-
Latest News5 days ago
MGA Publishes its 2024 Annual Report and Financial Statements
-
Interviews5 days ago
HIPTHER Community Voices: Interview with Dr. Maria Loumpourdi, founder and Managing Director of Made From Within
-
Affiliate Industry4 days ago
Meet MegaList: The Rising Force in iGaming Affiliation
-
Asia4 days ago
Bloomberry Resorts Corporation Appoints Gregory Francis Hawkins as Director, President and COO